Tuesday, January 10, 2023

New biomarker for early prediction of response to CAR-T cell therapy

A research team has discovered a highly potent biomarker for clinical response to CAR-T cell therapy, describing the prerequisites for optimal use of this novel therapy for lymphoma treatment. The current findings are an essential step forward towards optimizing this promising therapy.

from Top Health News -- ScienceDaily https://ift.tt/cEMD2Fm
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

New drugs could wipe out the “zombie cells” linked to cancer and aging

Researchers found a new way to kill harmful “zombie” cells that linger after chemotherapy and help cancers become more aggressive. These sen...